Analyst Ratings For Anika Therapeutics (NASDAQ:ANIK)
Today, Anika Therapeutics (NASDAQ:ANIK) stock received an upgrade by First Analysis from Equal Weight to Overweight with a price target of $68.00.
Some recent analyst ratings include
- 1/24/2018-First Analysis Upgrade from a “Equal Weight ” rating to a ” Overweight” rating.
- 12/28/2017-Barrington Research Reiterated Rating of Buy.
- 4/27/2016-Northland Securities was Downgraded by analysts at Northland Securities from a “Outperform ” rating to a ” Market Perform” rating.
Recent Insider Trading Activity For Anika Therapeutics (NASDAQ:ANIK)
Anika Therapeutics (NASDAQ:ANIK) has insider ownership of 6.57% and institutional ownership of 84.85%.
- On 11/30/2017 Richard Hague, Insider, sold 5,250 with an average share price of $54.48 per share and the total transaction amounting to $286,020.00.
- On 10/23/2017 Charles H Sherwood, CEO, sold 22,228 with an average share price of $60.06 per share and the total transaction amounting to $1,335,013.68.
- On 10/20/2017 Charles H Sherwood, CEO, sold 5,991 with an average share price of $60.04 per share and the total transaction amounting to $359,699.64.
- On 10/16/2017 Charles H Sherwood, CEO, sold 3,293 with an average share price of $60.04 per share and the total transaction amounting to $197,711.72.
- On 10/13/2017 Charles H Sherwood, CEO, sold 7,124 with an average share price of $60.08 per share and the total transaction amounting to $428,009.92.
- On 7/27/2017 Charles H Sherwood, CEO, sold 63,799 with an average share price of $50.79 per share and the total transaction amounting to $3,240,351.21.
- On 7/5/2017 Charles H Sherwood, CEO, sold 14,201 with an average share price of $50.03 per share and the total transaction amounting to $710,476.03.
Recent Trading Activity for Anika Therapeutics (NASDAQ:ANIK)
Shares of Anika Therapeutics closed the previous trading session at 61.16 up +1.78 3.00% with 60.0 shares trading hands.
